Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
YouTube’s upmarket TV push still runs on mid-funnel DNA
YouTube is balancing wanting to be premium TV, the short-form powerhouse and a creator economy engine all at once.
Digiday ranks the best and worst Super Bowl 2026 ads
Now that the dust has settled, it’s time to reflect on the best and worst commercials from Super Bowl 2026.
In the age of AI content, The Super Bowl felt old-fashioned
The Super Bowl is one of the last places where brands are reminded that cultural likeness is easy but shared experience is earned.